Blood count device co Sight Diagnostics raises $71m

Healthcare
Healthcare

Patients with Covid-19 who are in a moderate or serious condition need to undergo frequent blood count tests.

Israeli rapid blood diagnostics developer Sight Diagnostics has announced that it has raised $71 led by US corporations and international venture capital funds. Clal Biotechnology Industries Ltd. (TASE: CBI) notified the Tel Aviv Stock Exchange (TASE) that after the financing round it holds a 4% stake in Sight Diagnostics through Anatomy, its fund for investing in medical devices. Sight Diagnostics raised $28 million in February 2018.

Sight Diagnostics, which has developed a blood test for identifying Malaria, is now contributing to the war against Covid-19 through its lead product - a point-of-care blood count device, which is approved by the US Food and Drug Administration (FDA) and WHO.

Patients with Covid-19 who are in a moderate or serious condition need to undergo frequent blood count tests. Sight Diagnostics device gives swift results and is compact and easy to use.

In March, Sight Diagnostics cofounder and CEO Yossi Pollak said, "It's important to stress that we have not developed a test for coronavirus but a blood count test, which is important for all patients with fever who don't yet know what they have, and for all patients with a diagnosis to know if their condition is deteriorating. Our device has a lot to offer hospitals in termsof the spread of the disease and easing conducting tests in an isolated environment. It's a compact device trhat doesn't take up much space."

He added, "Our device is part of a strengthening trend during the coronavirus outbreak in which the world wants to conduct tests close to the patient. This is relevant for both coronavirus and other patients where institutions are looking to reduce exposure within the hospital."

Published by Globes, Israel business news - en.globes.co.il - on July 26, 2020 © Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Wix president Nir Zohar credit: Alan Tzatzkin Wix provides cautious 2025 guidance after strong 2024

The Israeli website building platform company reported its first-ever GAAP operating profit in 2024.

Saar Yoskovitz and Gal Shaul  / Photo: Augury Israeli industrial AI co Augury raises $75m

The new round represents an increase in valuation for Augury, which maintains its position as a ‘unicorn’ startup.

Eitan Yochananof and Eyal Ravid credit: Eyal Izhar and Tali Bogdanovsky Regulator indicts Victory, Yochananof CEOs over price fixing

The Israel Competition Authority today issued first indictments, following the food price fixing investigation.

Shekel credit: Shutterstock Vladirina 32 Shekel gains continue as Gaza talks progress

The shekel continues to trade at its strongest levels against the dollar since early 2023.

New York credit: Shutterstock Tel Aviv - New York fares stay high despite US airlines return

Ticket prices to the US will continue to cost at least $1,200 return, according to Ophir Tours, with most fares ranging between $1,500 and $2,000, or even more.

Greenfield Partners team credit: Eyal Toueg Greenfield Partners closes $400m third fund

The funds were raised from institutional investors in Israel, the US, Europe and Asia and brings the total funds under management to more than $1 billion.

Blockaid founders Ido Ben-Natan and Raz Niv credit: Liron Weissman Israeli onchain security co Blockaid raises $50m

Blockaid protects the largest companies building onchain, including Coinbase, Metamask, Stellar, Uniswap, and World App.

Air Haifa  credit: ATR Air Haifa to launch Paphos flights

New Israeli airline Air Haifa will launch a new route between Haifa and Paphos in Cyprus on April 3, 2025 with six weekly flights.

Bladeranger Deepsolar credit: PR Bladeranger divests Deepsolar to Painreform in strategic move

Deepsolar, acquired by Bladeranger in early 2023, is a sophisticated software solution designed to optimize the management of photovoltaic solar energy fields.

Traffic jam on the Ayalon Highway in Tel Aviv credit: Shutterstock Tender issued for operating Tel Aviv congestion charge

Minister of Transport Miri Regev has dropped her opposition to the project, reportedly in exchange for financing railways to Kiryat Shmona and Eilat.

Ilya Sutskever credit: Cadya Levy Ilya Sutskever's SSI raising money at $30b valuation - report

The AI startup founded last year by OpenAI founder and former chief scientist Ilya Sutskever, is in talks to raise money at a company valuation of over $30 billion, "Bloomberg" reports.

Dina Ben Tal Ganancia  credit: Guy Kushi & Yariv Fein El Al stock still rising despite return of foreign airlines

The Israeli carrier's share price has risen 35% since the start of the year and some analysts predict further gains.

NIS 200 bills credit: Tali Bogdanovsky Reduction in cash holdings after NIS 200 bill abolishment talk

Since September 2024 there has been a dramatic decline in the number of NIS 200 bills held by the public relative to the number of NIS 100 bills, according to Bank of Israel data.

Teva CEO Richard Francis credit: Elad Malka Teva CEO responds to 25% share price fall

Richard Francis said that the question is no longer whether Teva will survive but whether it can grow more.

Holon employment bureau credit: Eyal Izhar Unemployment in Israel fell in January

The unemployment rate in Israel fell to 2.6% in January 2025, after seasonal adjustment, from 2.7% in December 2024, the Central Bureau of Statistics reports.

Dizengoff Center credit: Guy Hamoy Israel's economy grew 1% in 2024, above expectations

This figure reflects negative GDP per capita growth of 0.3%, because of population growth last year, the Central Bureau of Statistics reports.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018